Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
<p><strong>Background</strong></p> <p>Risk assessment is relevant to predict postoperative outcomes in patients with gastro‐oesophageal cancer. This cohort study aimed to assess body composition changes during neoadjuvant chemotherapy and investigate their association w...
Main Authors: | den Boer, RB, Jones, KI, Ash, S, van Boxel, GI, Gillies, RS, O’Donnell, T, Ruurda, JP, Sgromo, B, Silva, MA, Maynard, ND |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Wiley
2020
|
Registos relacionados
-
Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
Por: Millo, J, et al.
Publicado em: (2003) -
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
Por: Gillies, R, et al.
Publicado em: (2012) -
Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
Por: Rana, M, et al.
Publicado em: (2021) -
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
Por: Gillies, R, et al.
Publicado em: (2012) -
Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
Por: Gillies, R, et al.
Publicado em: (2012)